SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-17-001067
Filing Date
2017-02-13
Accepted
2017-02-13 11:15:50
Documents
1
Group Members
PATRICK G. G. DEARPOLYGON CONVERTIBLE OPPORTUNITY MASTER FUNDPOLYGON GLOBAL PARTNERS LLPPOLYGON GLOBAL PARTNERS LPPOLYGON MANAGEMENT LTD.READE E. GRIFFITHTFG ASSET MANAGEMENT L.P

Document Format Files

Seq Description Document Type Size
1 SYNERGY PHARMACEUTICALS, INC. p17-0605sc13ga.htm SC 13G/A 126135
  Complete submission text file 0000902664-17-001067.txt   128162
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Subject) CIK: 0001347613 (see all company filings)

IRS No.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-86352 | Film No.: 17596967
SIC: 2834 Pharmaceutical Preparations

Mailing Address PO BOX 309 UGLAND HOUSE GRAND CAYMAN E9 KY1-1104
Business Address PO BOX 309 UGLAND HOUSE GRAND CAYMAN E9 KY1-1104 212-359-7356
Polygon Management Ltd. (Filed by) CIK: 0001515070 (see all company filings)

IRS No.: 980646182 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A